Direct IFNluence of interferon-γ on proliferation and cell-surface antigen expression of non-small cell lung cancer cells

Lung Cancer

Volumn 30, Issue 3, 2000, Pages 169-174

  Yano, Tokujiro ^a   Sugio, Kenji ^b   Yamazaki, Koji ^b   Kase, Shinichiro ^b   Yamaguchi, Masafumi ^b   Ondo, Kaoru ^b   Sugimachi, Keizo ^b  

^a NATIONAL HOSPITAL ORGANIZATION KYUSHU MEDICAL CENTER   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

Author keywords

CEA; HLA class I; HLA class II; IFN ; Lung cancer; Proliferation

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; GAMMA INTERFERON; HLA ANTIGEN CLASS 1; HLA ANTIGEN CLASS 2; MONOCLONAL ANTIBODY; PROTEIN P53;

ADENOCARCINOMA; ANTIGEN EXPRESSION; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER INHIBITION; CELL CYCLE G1 PHASE; CELL CYCLE G2 PHASE; CELL CYCLE S PHASE; CONTROLLED STUDY; DOSE RESPONSE; EXON; GENE MUTATION; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; LUNG NON SMALL CELL CANCER; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SINGLE STRAND CONFORMATION POLYMORPHISM; SQUAMOUS CELL CARCINOMA;

ANTIGENS, SURFACE; CARCINOMA, NON-SMALL-CELL LUNG; CELL DIVISION; DOSE-RESPONSE RELATIONSHIP, DRUG; HISTOCOMPATIBILITY ANTIGENS; HUMANS; INTERFERON TYPE II; LUNG NEOPLASMS; RNA PROCESSING, POST-TRANSCRIPTIONAL; TUMOR CELLS, CULTURED;

EID: 0034530166     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-5002(00)00136-7     Document Type: Article

References (10)

1. Expression of HLA-D subloci DR and DQ by breast carcinomas is correlated with distinct parameters of favourable prognosis
2. Histocompatibility antigens in primary and metastatic squamous cell carcinoma of the larynx
3. Cytotoxic activity of lymphocytes to bronchogenic carcinoma cells in patients with lung cancer
4. Interleukin-2 receptors in pulmonary adenocarcinoma tissue
5. A sensitive and high-resolution method for the detection of mutations in the p53 gene using fluorescence-based PCR-SSCP
6. Induction of HLA class-II antigen expression on human carcinoma cell lines by IFN-γ
7. HLA class I and class II expression of pulmonary adenocarcinoma cells and the IFNluence of interferon γ
8. KIP1 that prevent activation of cyclin-dependent kinase by CDK-activating kinase (CAK)
9. Cell growth arrest and induction of cyclin-dependent kinase inhibitor p21WAF1/CIP1 mediated by STAT1
10. KIP1 in γ interferon-mediated growth arrest of mammary epithelial cells and related defects in mammary carcinoma cells